EUVIMEDEUVIMED entdecken
Crossref

Use of Dolutegravir to Treat People Living With HTLV-1–associated Myelopathy (HAM)

Jorge Casseb iD, Tatiane Assone, Augusto César Penalva de Oliveira

Clinical Infectious Diseases · 21.05.2026

DOI: 10.1093/cid/ciag323 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Clinical Infectious Diseases, online erschienen am 21.05.2026. Verfasst von Jorge Casseb und 2 weiteren Autor:innen. Beteiligte Einrichtung: Departamento de Dermatologia, Faculdade de Medicina da Universidade de São Paulo, São Paulo, Brazil. Die Arbeit nennt 7 Literaturangaben.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Autor:innen und Institutionen

  • Departamento de Dermatologia, Faculdade de Medicina da Universidade de São Paulo, São Paulo, Brazil.
  • Departamento de Medicina Legal, Bioética, Medicina do Trabalho e Medicina Física e Reabilitação, Faculdade de Medicina da Universidade de São Paulo, São Paulo, Brazil.
  • Instituto de Infectologia Emilio Ribas, Secretaria de Saúde do Estado de São Paulo, São Paulo, Brazil.

ORCID-Profile: Jorge Casseb

Zitieren

APA

Casseb, J., Assone, T., & de Oliveira, A. C. P. (2026). Use of Dolutegravir to Treat People Living With HTLV-1–associated Myelopathy (HAM). Clinical Infectious Diseases. https://doi.org/10.1093/cid/ciag323

Vancouver

Casseb J, Assone T, de Oliveira ACP. Use of Dolutegravir to Treat People Living With HTLV-1–associated Myelopathy (HAM). Clinical Infectious Diseases. 2026. doi:10.1093/cid/ciag323

BibTeX
@article{Casseb2026,
  author = {Casseb, Jorge and Assone, Tatiane and de Oliveira, Augusto César Penalva},
  title = {Use of Dolutegravir to Treat People Living With HTLV-1–associated Myelopathy (HAM)},
  journal = {Clinical Infectious Diseases},
  year = {2026},
  doi = {10.1093/cid/ciag323}
}
Kostenlos starten →